48,830
edits
Difference between revisions of "Gross cystic disease fluid protein-15"
Jump to navigation
Jump to search
m
Gross cystic disease fluid protein-15 (view source)
Revision as of 15:42, 28 September 2018
, 15:42, 28 September 2018mamma
(tweak) |
m (mamma) |
||
| Line 3: | Line 3: | ||
It is also known as '''BRST-2'''.<ref name=pmid8693878>{{Cite journal | last1 = Fiel | first1 = MI. | last2 = Cernaianu | first2 = G. | last3 = Burstein | first3 = DE. | last4 = Batheja | first4 = N. | title = Value of GCDFP-15 (BRST-2) as a specific immunocytochemical marker for breast carcinoma in cytologic specimens. | journal = Acta Cytol | volume = 40 | issue = 4 | pages = 637-41 | month = | year = | doi = | PMID = 8693878 }}</ref> | It is also known as '''BRST-2'''.<ref name=pmid8693878>{{Cite journal | last1 = Fiel | first1 = MI. | last2 = Cernaianu | first2 = G. | last3 = Burstein | first3 = DE. | last4 = Batheja | first4 = N. | title = Value of GCDFP-15 (BRST-2) as a specific immunocytochemical marker for breast carcinoma in cytologic specimens. | journal = Acta Cytol | volume = 40 | issue = 4 | pages = 637-41 | month = | year = | doi = | PMID = 8693878 }}</ref> | ||
It is much less sensitive than | It is much less sensitive than mammaglobin.<ref>{{Cite journal | last1 = Bhargava | first1 = R. | last2 = Beriwal | first2 = S. | last3 = Dabbs | first3 = DJ. | title = Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity. | journal = Am J Clin Pathol | volume = 127 | issue = 1 | pages = 103-13 | month = Jan | year = 2007 | doi = 10.1309/TDP92PQLDE2HLEET | PMID = 17145637 }}</ref> | ||
==Microscopic== | ==Microscopic== | ||